11 Nov 2019 Évaluation de la prise en charge des cas de paludisme grave en RDC La présente étude a été réalisée pour identifier les obstacles et les opportunités rencontrés dans la prise en charge du paludisme grave afin de réduire la mortalité associée à cette maladie en RDC.
4 Feb 2020 Injectable Artesunate Assessment Report Since the ISMO project, few efforts have been undertaken to understand to what extent injectable artesunate has become (or remained) the preferred drug to treat severe malaria in the ISMO countries or in other malaria-endemic countries globally and, particularly, in sub-Saharan Africa, where most deaths from malaria occur. This report describes the findings of an assessment intended to answer this question.
Defeating an old foe, malaria, while surviving a new enemy, Covid-19 – Rebecca Akufo-Addo 2 July 2020 is the second anniversary of the Pan-African ‘Zero Malaria Starts with Me’ movement, which calls for the elimination of malaria across Africa. 02 Jul 2020
MMV and LSTM collaborate to fill data gap on use of antimalarials during pregnancy On this International Women’s Day, the Swiss-based Product Development Partnership, MMV and LSTM announce a collaboration to establish a pregnancy registry in malaria-endemic countries in Africa to help fill the data gap on the use of antimalarial medicines during pregnancy. 08 Mar 2020
World Malaria report 2019 launched The World malaria report 2019 provides a comprehensive update on global and regional malaria data and trends. 04 Dec 2019
Country leaders pledge to boost malaria innovation and access to new and existing antimalarials Pledge comes as researchers and programme delivery experts come together to celebrate Medicines for Malaria Venture’s 20th anniversary. 11 Nov 2019
20 Mar 2020 Blood group and size dependent stability of & P. falciparum & infected red blood cell aggregates in capillaries. For related malaria (B50), one of the outstanding host factors for the development of severe disease is the ABO blood group of malaria patients, where blood group O reduces the probability of severe disease as compared to individuals of groups A, B, or AB.
16 Mar 2020 Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic Africa needs to be prepared to deal with COVID-19, given the infectious potential of the disease and its capacity to undermine malaria control efforts.
12 Mar 2020 Malaria Case Fatality Rate among Children under Five in Burkina Faso: An Assessment of the Spatiotemporal Trends Following the Implementation of Control Programs. The findings of this research highlighted locations in Burkina Faso that are most in need of targeted interventions and the necessity to sustain and strengthen the launched health programs to further reduce the malaria deaths in Burkina Faso.
